FOXM1-AKT Positive Regulation Loop Provides Venetoclax Resistance in AML
Forkhead box protein M1 (FOXM1) is a crucial regulator of cancer development and chemoresistance. It is often overexpressed in acute myeloid leukemia (AML) and is associated with poor survival and reduced efficacy of cytarabine therapy. Molecular mechanisms underlying high FOXM1 expression levels in...
Main Authors: | Mikhail S Chesnokov, Soheila Borhani, Marianna Halasi, Zarema Arbieva, Irum Khan, Andrei L. Gartel |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.696532/full |
Similar Items
-
Novel FOXM1 inhibitor identified via gene network analysis induces autophagic FOXM1 degradation to overcome chemoresistance of human cancer cells
by: Mikhail S. Chesnokov, et al.
Published: (2021-07-01) -
Suppression of FOXM1 sensitizes human cancer cells to cell death induced by DNA-damage.
by: Marianna Halasi, et al.
Published: (2012-01-01) -
FoxM1 is a general target for proteasome inhibitors.
by: Uppoor G Bhat, et al.
Published: (2009-08-01) -
Thiazole antibiotics siomycin A and thiostrepton inhibit the transcriptional activity of FOXM1
by: Andrei L Gartel
Published: (2013-06-01) -
Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells.
by: Uppoor G Bhat, et al.
Published: (2009-01-01)